- Schrödinger (SDGR, Financial) to release Q1 2025 financial results on May 7, 2025.
- The conference call and webcast are scheduled for 4:30 p.m. ET.
- Webcast replay will be available for 90 days post-event.
Schrödinger (SDGR), a leader in molecular discovery, announced that it will unveil its first quarter 2025 financial results on Wednesday, May 7, 2025. The announcement will occur post-market close, giving investors and stakeholders insight into the company's recent performance.
The company has scheduled a conference call and webcast at 4:30 p.m. ET on the same day. Interested parties can access the live webcast through the “Investors” section of Schrödinger’s official website. The webcast will remain available for replay for approximately 90 days following the event, providing ample opportunity for those unable to attend live.
Schrödinger, established in 1990 and headquartered in New York, focuses on transforming molecular discovery through its cutting-edge computational platform. The company's software aids in the discovery of new, highly optimized molecules for drug development and materials design. Schrödinger is currently advancing three clinical-stage oncology programs and serves a global clientele comprising biotechnology, pharmaceutical, and industrial companies, along with academic institutions.
With a market capitalization of $1.87 billion and a strong institutional ownership of 97.93%, Schrödinger continues to be a significant player in the health information services industry under the pharmaceutical preparations sector.
